• We The Patients Fly-In
  • Events Calendar
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
  • Donate

Actions

Urge the FTC to study the perverse practices of Pharmacy Benefit Managers (PBMs)

Urge the FTC to study the perverse practices of Pharmacy Benefit Managers (PBMs)

May 11, 2022 | Actions, Featured, Featured Action, Pharmacy Benefit Managers

Urge the FTC to study the perverse practices of Pharmacy Benefit Managers (PBMs) On February 24, the Federal Trade Commission (FTC) issued a solicitation for comment regarding Pharmacy Benefit Managers (PBMs) and the impact PBMs have on patients, among others. You can...
Read more
Lend Your Voice to Support the Improving Seniors’ Timely Access to Care Act of 2021.

Lend Your Voice to Support the Improving Seniors’ Timely Access to Care Act of 2021.

Jan 26, 2022 | Actions, Federal Issues

This legislation is the culmination of months of bipartisan, bicameral discussions that included full engagement with all involved stakeholders, resulting in balanced, common-sense legislation that would help protect patients from unnecessary delays in care by...
Read more
Lend your voice to support the Help Ensure Lower Patient (HELP) Copays Act

Lend your voice to support the Help Ensure Lower Patient (HELP) Copays Act

Nov 10, 2021 | Actions, Featured, Featured Action

Lend your voice to support the Help Ensure Lower Patient (HELP) Copays Act Millions of vulnerable Americans across the country rely on cost-sharing assistance to afford the medicines they need. Patients in the private health insurance market have increasingly relied...
Read more
Ensure Patient Perspectives Are Included in FDA Benefit-Risk Assessments

Ensure Patient Perspectives Are Included in FDA Benefit-Risk Assessments

Nov 5, 2021 | Actions, Featured, Featured Action

Ensure Patient Perspectives Are Included in FDA Benefit-Risk Assessments Lend your voice to support the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act. Congress and the Food and Drug Administration (FDA) have made considerable...
Read more
Ban Co-pay Accumulator Programs in Massachusetts

Ban Co-pay Accumulator Programs in Massachusetts

Sep 16, 2021 | Actions, Copay Accumulators, Featured, Letters Supported, Massachusetts

Show your support for S. 644 and H.1053 which would ban co-pay accumulator programs in Massachusetts. Many Insurers and PBMs are now utilizing copay accumulators to stop copay assistance from counting towards a patient’s deductible and maximum out-of-pocket spending....
Read more
Comment Solicitation on Policy Modifications on Non-Opioid Pain Management Drugs

Comment Solicitation on Policy Modifications on Non-Opioid Pain Management Drugs

Sep 10, 2021 | Access, Actions, Federal Issues, Medicare

There is a constant drum beat around the rising cost of drug prices, with little discussion of the benefit design in plans whether they are government or employer sponsored. Medicare Part B requires patients without supplemental coverage to pay a 20% copay on all...
Read more
« Older Entries

Categories

  • Access
  • Actions
  • California
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA H.R.3 Healthcare Inequities Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden Lupus medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Can Mark Cuban Deliver Cheaper RX? – Season 3 | Episode 20
  • What is the Future of Co-pay Accumulator and Maximizer Programs? 
  • Have Health Plans Abandoned Rare Disease Patients?: Season 3 | Episode 19
  • Patients Rising Now Pens Letter Regarding S.2910: The Expanding Access to Low-Cost Generics Act of 2021
  • OIG Report Tags Biosimilars for Medicare and Beneficiary Savings

Sign up for updates

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2022 Patients Rising Now